Amy Chappell
Förmögenhet: 1 105 $ per 2026-09-30
Förmögenhet: 1 105 $ per 2026-09-30
Amy S.
Chappell is currently an Independent Director at BioVie, Inc. since 2025 and Chief Medical Officer at Solaxa, Inc. since 2024.
Formerly, Dr. Chappell was Chief Medical Officer at Climb Bio, Inc. from 2020 to 2021.
Education includes undergraduate studies at Antioch College and a doctorate from The Indiana University School of Medicine.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
BIOVIE INC. CLASS A 0,01 % | 2026-08-31 | 727 ( 0,01 % ) | 1 105 $ | 2026-09-30 |
| Företag | Position | Start |
|---|---|---|
| BIOVIE INC. | Direktör/Styrelseledamot | 2025-07-22 |
| Företag | Position | Slut |
|---|---|---|
| CLIMB BIO, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2021-12-31 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 4 |
|---|---|
BioVie, Inc.
BioVie, Inc. BiotechnologyHealth Technology Develops drug therapies for chronic debilitating conditions | Health Technology |
Antioch College
Antioch College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Indiana University School of Medicine
The Indiana University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eliem Therapeutics, Inc.
Eliem Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån